Biography
Abel has over 20 years in the field of bioinformatics, data and knowledge management and a scientific background in molecular biology and immuno-virology (PhD from the Pasteur Institute, France). In 1999, he joined the bioinformatics team at Genoscope (Evry, France) in the ramp up of the human genome project. In 2001, he moved to the European Bioinformatics Institute (Cambridge, UK) where he led the Ensembl comparative genomics team until 2007. He founded Eagle Genomics shortly before graduating from the Cambridge Judge Business School MBA program in 2008. For nearly 12 years, he was one of the driving forces within the executive team at Eagle Genomics, supporting the strategy, funding and partnership activities of the company. In Spring 2020 he exited Eagle Genomics and joined the CMS Ventures fund as well as getting involved more formally in a couple of innovative startups in the Life Sciences, namely Sofi Health and Nanograb. Since 2021 Abel has been Venture Partner at Nina Capital, and later in 2022 joined Octiocor, a cardiology AI spinout of Cambridge University as CEO.